Reuters - Cancer findings in a new study of
cholesterol drug Vytorin are “likely to be an anomaly”
unrelated to the drug, makers Merck & Co and Schering-Plough
Corp said in a letter to doctors.
Independent honest reviews of most effective natural herbal supplements
Reuters - Cancer findings in a new study of
cholesterol drug Vytorin are “likely to be an anomaly”
unrelated to the drug, makers Merck & Co and Schering-Plough
Corp said in a letter to doctors.
The URI to TrackBack this entry is: http://herbal-review.com/2008/07/23/vytorin-makers-say-cancer-results-likely-an-anomaly-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|No results yet!
23 queries. 0.695 seconds